Company Information
USD
27.7
- (1.9%)
NYSE:PFE, PFIZER INC.
Industry: Drug Manufacturers - General
End of Day: 2 May 2024 GMT-4
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Address
66 Hudson Boulevard East
Website
Classification
Sector
Healthcare
Industry Group
Drug Manufacturers
Industry
Drug Manufacturers - General
Key Executives
Mr. David M. Denton
CFO/Executive VP
Ms. Lidia L. Fonseca
Chief Technology Officer/Executive VP/Other Executive Officer
Ms. Sally Susman
Executive VP/Other Executive Officer
Mr. Ronald E. Blaylock
Director
Mr. Shantanu Narayen
Director
Ms. Suzanne Nora Johnson
Director
Dr. Scott Gottlieb,M.D.
Director
Mr. James Robert Quincey
Director
Dr. Susan J. Hockfield, PhD
Director
Dr. Susan D. Desmond-Hellmann,M.D.
Director
Dr. Mikael Dolsten, M.D.,PhD
Chief Scientific Officer/President, Divisional
Mr. Douglas M. Lankler
Executive VP/General Counsel
Mr. James C. Smith
Director
Dr. Helen H. Hobbs
Director
Mr. Rady A. Johnson
Chief Compliance Officer/Chief Risk Officer/Executive VP/Other Executive Officer
Dr. Albert Bourla, D.V.M.,PhD
CEO/Chairman of the Board/Director
Mr. Joseph J. Echevarria
Director
Ms. Margaret M. Madden
Other Corporate Officer/Secretary/Senior VP
Mr. Dan R. Littman
Director
Ms. Jennifer B. Damico
Chief Accounting Officer/Controller/Senior VP
Ms. Payal Sahni
Executive VP/Other Executive Officer
Mr. Aamir Malik
Executive VP/Other Executive Officer
Mr. Michael McDermott
Executive VP/Other Executive Officer
Dr. Chris Boshoff, M.D.,PhD
Executive VP/Other Executive Officer
Mr. Alexandre de Germay
Executive VP/Other Executive Officer
Ownership
Institution Holdings
Vanguard Group Inc
506,510,999 (8.970%)
BlackRock Inc
432,503,754 (7.659%)
State Street Corporation
287,482,006 (5.091%)
Wellington Management Company LLP
239,209,768 (4.236%)
Capital Research and Management Company
182,446,649 (3.231%)
Vanguard Investments Australia Ltd
180,566,162 (3.198%)
Capital World Investors
173,394,272 (3.071%)
BlackRock Fund Advisors
147,962,650 (2.620%)
Geode Capital Management, LLC
109,534,217 (1.940%)
Charles Schwab Investment Management Inc
104,246,432 (1.846%)
Funds Holdings
Vanguard US Total Market Shares ETF
177,533,046 (3.144%)
Vanguard Total Stock Market Index Fund
177,533,046 (3.144%)
Vanguard Institutional 500 Index Trust
139,544,109 (2.471%)
Fidelity 500 Index Fund
67,038,517 (1.187%)
SPDR® S&P 500 ETF Trust
66,278,936 (1.174%)
Schwab US Dividend Equity ETF™
65,516,488 (1.160%)
Vanguard Health Care Fund
59,600,594 (1.055%)
iShares Core S&P 500 ETF
58,743,818 (1.040%)
American Funds Washington Mutual Fund
52,489,724 (0.930%)
Capital Group Wash Mutual Invtrs Comp
52,489,724 (0.930%)
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
